Semaglutide in Treatment of Obesity

Clinical trial NCT06604624 · COMPLETED

Trial details

NCT number: NCT06604624
Sponsor: CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Weight Management

Start date: 2024-09-20
Primary completion: 2025-08-27
Enrollment: 462

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.